Yawara Kawano

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 380 citations

Medicine, Pharmacology, Pharmacotherapy +12

CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation

Aldo M. Roccaro, Yuji Mishima, Antonio Sacco et al. · Cell Reports · 2015 · 143 citations · Full text

Medicine, Cancer Biology, Oncology +17

PDK1 inhibition is a novel therapeutic target in multiple myeloma

Saori Fujiwara, Yawara Kawano, Hiromichi Yuki et al. · British Journal of Cancer · 2012 · 139 citations · Full text

Medicine, Oncology, Pharmacology +17

Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide

Yawara Kawano, Shiho Fujiwara, Naoko Wada et al. · International Journal of Oncology · 2012 · 115 citations · Full text

Medicine, Cell Biology, Hematology +16

Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression

Yawara Kawano, Oksana Zavidij, Jihye Park et al. · Journal of Clinical Investigation · 2018 · 111 citations · Full text

Life Sciences, Cell Biology, Immunology +17